ALLISON SMITH: Open Payments
NPI 1619403847 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,110 in 154 payments from 18 companies in 2025. Trend: 2023 $1,503 · 2024 $4,227 · 2025 $4,110
Food & beverage: $4,011Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $666 |
| GENZYME CORPORATION | 19 | $373 |
| Janssen Biotech, Inc. | 17 | $370 |
| E.R. Squibb & Sons, L.L.C. | 11 | $361 |
| PFIZER INC. | 9 | $349 |
| UCB, Inc. | 9 | $240 |
| Incyte Corporation | 8 | $236 |
| Galderma Laboratories, L.P. | 5 | $222 |
| Organon LLC | 3 | $196 |
| LEO Pharma Inc. | 16 | $185 |
Products named: DUPIXENT, TREMFYA, Sotyktu, RINVOQ, Bimzelx, OPZELURA, CIBINQO, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
